Focus on the use of Green Tea in cancer setting: between lights and shadows
WCRJ 2023;
10
: e2581
DOI: 10.32113/wcrj_20236_2581
Topic: Complementary and alternative medicine
Category: Opinion paper
Abstract
Green tea (GT) is a beverage derived from the unfermented leaves of Camellia sinensis, a plant native to Asia. Green tea extract is marketed as an antioxidant and dietary supplement to support cardiovascular, metabolic, cognitive, and cellular health. Data on the use of GT in oncology are controversial, mainly because of the risk of interference with anticancer drugs. To date, the use of GT is recommended as supportive treatment in most oncological diseases.
To cite this article
Focus on the use of Green Tea in cancer setting: between lights and shadows
WCRJ 2023;
10
: e2581
DOI: 10.32113/wcrj_20236_2581
Publication History
Submission date: 19 May 2023
Revised on: 08 Jun 2023
Accepted on: 19 Jun 2023
Published online: 20 Jun 2023
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.